Promising Adjuvants and Platforms for Influenza Vaccine Development is a research paper published in Pharmaceutics (2021). On theSindex it has a DataRank of 0.524. It has been cited 32 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.524
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01AI101047, R01AI116835, and R01AI143844
NIAID NIH HHS
Grant: R01 AI143844
NIAID NIH HHS
Grant: R01 AI116835
NIAID NIH HHS
Grant: R01 AI101047
National Institutes of Health
Grant: 1R01AI116835-01
Novel vaccine to enhance breadth of influenza immunity by skin vaccination
National Institutes of Health
Grant: 5R01AI101047-08
Novel Influenza nano vaccines for broad cross protection
National Institutes of Health
Grant: 5R01AI143844-05
Multivalent nanocluster universal influenza vaccine given by microneedle patch
FWCI
3.85
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals